Short Description

NGS genetic DNA test detecets for variant and mutation detection in ATP13A2 gene for PARK9 Parkinson

PreTest Information

Clinical History of Patient who is going for ATP13A2 Gene PARK9 Parkinson NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ATP13A2 Gene PARK9 Parkinson

Detail Description

ATP13A2 Gene PARK9 Parkinson NGS Genetic DNA Test Cost INR:20000 Symptoms Diagnosis

Parkinson's disease is a degenerative disorder that affects the central nervous system. It is characterized by tremors, rigidity, and difficulty in movement. The cause of Parkinson's disease is still unknown, but recent research has identified several genes that may contribute to the development of the disease. One such gene is the ATP13A2 gene, also known as the PARK9 gene.

The ATP13A2 gene provides instructions for making a protein that is involved in the transport of certain molecules within cells. Mutations in the ATP13A2 gene have been linked to an increased risk of developing Parkinson's disease. These mutations are rare, but they can have a significant impact on the development and progression of the disease.

Symptoms of Parkinson's Disease

The symptoms of Parkinson's disease can vary from person to person, but some of the most common symptoms include:

• Tremors
• Rigidity
• Bradykinesia (slowness of movement)
• Postural instability
• Difficulty with balance and coordination

Diagnosis of Parkinson's Disease

Diagnosing Parkinson's disease can be challenging, as there are no specific tests that can confirm the presence of the disease. Instead, doctors rely on a combination of medical history, physical examination, and neurological testing to make a diagnosis. Imaging tests, such as MRI or CT scans, may also be used to rule out other conditions that can cause similar symptoms.

ATP13A2 Gene PARK9 Parkinson NGS Genetic DNA Test

The ATP13A2 gene PARK9 Parkinson NGS genetic DNA test is a genetic test that can help identify mutations in the ATP13A2 gene that may increase the risk of developing Parkinson's disease. The test is performed using next-generation sequencing (NGS) technology, which allows for the analysis of multiple genes at once.

The cost of the ATP13A2 gene PARK9 Parkinson NGS genetic DNA test in India is approximately INR 20,000. The test is typically performed on a blood sample, which is sent to a specialized laboratory for analysis. Results are usually available within a few weeks.

Conclusion

The ATP13A2 gene PARK9 Parkinson NGS genetic DNA test can be a valuable tool in the diagnosis and management of Parkinson's disease. By identifying mutations in the ATP13A2 gene, doctors can better understand a patient's risk of developing the disease and tailor treatment options accordingly. If you are concerned about your risk of developing Parkinson's disease, speak to your doctor about whether the ATP13A2 gene PARK9 Parkinson NGS genetic DNA test may be right for you.

Remember, early detection and treatment can make a significant difference in the outcome of Parkinson's disease, so don't hesitate to seek medical advice if you are experiencing symptoms.

For more information on genetic testing and Parkinson's disease, visit DNA Labs India.